Cardioneuroablation can be performed to decrease syncope recurrence in adult patients aged < 60 years, with severe or recurrent cardioinhibitory syncope without prodromal symptoms, after proven failure of conventional therapies. Due to a paucity of data supporting efficacy in older individuals or for vasodepressor components, CNA in adult patients aged > 60 years or in the presence of a dominant vasodepressor should be considered investigational in severely symptomatic patients after proven failure of pharmacological and non-pharmacological therapies.
Keyphrases
- pulmonary embolism
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- clinical trial
- prognostic factors
- parkinson disease
- electronic health record
- machine learning
- big data
- early onset
- physical activity
- randomized controlled trial
- depressive symptoms
- middle aged
- deep learning
- artificial intelligence
- community dwelling
- patient reported